PATENT CLAIM ANALYSIS

Application Number: 15778062
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["424", "204100"]

Abstract:
The present invention provides a preparation method for PCV2 capsid protein and a pharmaceutical composition containing said capsid protein. The method of the present invention uses a novel arabinose-induced expression vector and thereby improves the synthesis efficiency of said PCV2 capsid protein. On the other hand, the present pharmaceutical composition combines said capsid protein and other favorable components at a proper ratio so that achieves excellent immune-inducing effects.

Claim (Index 20):
A composition for preventing porcine circovirus type 2 (PCV2) infection, comprising:\n 2.5 to 250 \u03bcg/mL PCV2 capsid protein; 2.5 to 25 \u03bcg/mL porcine interferon-\u03b1; 2.5 to 25 \u03bcg/mL porcine interferon-\u03b3; and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 93.0
- Lexical Diversity: 1.63636
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14946384', '14363341', '11920877', '13808974', '14763121']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7566863246602141
- 35 USC 102 Novelty (BERT): 0.5367591187949398
- Combined Prediction Score: 0.7346936040736867
- Mean Citation Score: 375.66279
- Max Citation Score: 388.4445
- Similarity Product: 267.3198168865443

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test